Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor α production of monocytes

被引:228
作者
Aosasa, S [1 ]
Ono, S [1 ]
Mochizuki, H [1 ]
Tsujimoto, H [1 ]
Ueno, C [1 ]
Matsumoto, A [1 ]
机构
[1] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 3598513, Japan
来源
SHOCK | 2001年 / 15卷 / 02期
关键词
monocyte; TNF alpha; IL-10; cytokine; NF kappa B; protease inhibitor; gabexate mesilate; ulinastatin;
D O I
10.1097/00024382-200115020-00004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
If the inflammatory response becomes excessive or uncontrolled by some stimuli, inappropriate inflammatory responses occur. Monocytes are extremely important cells for regulating the cytokine network and tumor necrosis factor alpha (TNF alpha) and interleukin- (IL) 10, which are mainly synthesized by monocytes, are representative cytokines that play a central role in the cytokine network. Protease inhibitors such as gabexate mesilate (GM) and ulinastatin (UTI) have been shown to have various beneficial effects by inhibiting the activation of leukocytes, but the mechanism for this has yet to be fully elucidated. In this study we investigated the mechanism of the inhibitory effect of protease inhibitors on the proinflammatory cytokine production of lipopolysaccharide- (LPS) stimulated monocytes. LPS-stimulated monocytes were treated with G M or UTI, The value of TNF alpha and IL-10 in the cultu re medium of monocytes was measured and each mRNA expression was assayed. The inhibitory effect of protease inhibitors on the activity of intracellular signal transduction pathways such as protein kinase C (PKC) and nuclear factor kappa B (NFkappaB) were also evaluated. GM decreased the TNF alpha production of LPS-stimulated monocytes as shown by the inhibition of mRNA expression and increased the IL-10 production of LPS-stimulated monocytes. GM also suppressed the NFkappaB activity of LPS-stimulated monocytes. UTI decreased the TNF alpha production of LPS-stimulated monocytes, but did not inhibit the TN For m RNA expression. The present study shows that the inhibitory effect of GM on the TNF alpha production of activated human monocytes is mediated by the suppression of NFkappaB activation, while the mechanism of UTI inhibiting TNF alpha production of human monocytes may be due to the inhibition of either the translation or secretion of TNF alpha.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 35 条
  • [1] CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON
    AGGARWAL, BB
    EESSALU, TE
    HASS, PE
    [J]. NATURE, 1985, 318 (6047) : 665 - 667
  • [2] Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B-2 production in human monocytes
    Aibiki, M
    Cook, JA
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (03) : 430 - 434
  • [3] Inhibitory effect of protease inhibitor on endothelial cell activation
    Aosasa, S
    Ono, S
    Seki, S
    Takayama, E
    Tadakuma, T
    Hiraide, H
    Mochizuki, H
    [J]. JOURNAL OF SURGICAL RESEARCH, 1998, 80 (02) : 182 - 187
  • [4] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [5] MACROPHAGE DEACTIVATION BY INTERLEUKIN-10
    BOGDAN, C
    VODOVOTZ, Y
    NATHAN, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) : 1549 - 1555
  • [7] Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography
    Cavallini, G
    Tittobello, A
    Frulloni, L
    Masci, E
    Mariani, A
    DiFrancesco, V
    Angelini, GP
    Casarini, MB
    Bedogni, G
    Conigliaro, R
    Bonardi, L
    Khajekini, MTA
    Cipolletta, L
    Bianco, MA
    Costamagna, G
    Perri, V
    Dobrilla, G
    DePretis, G
    Familiari, L
    Giacobbe, G
    Fratton, A
    Carone, N
    Loriga, P
    Muscas, A
    Mazzeo, F
    Gaeta, L
    Miglioli, M
    Pezzilli, R
    Morelli, A
    Santucci, L
    Naccarato, R
    DelFavero, G
    Orlandi, F
    Macarri, GP
    Russo, A
    Virgilio, C
    Uomo, G
    Manes, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (13) : 919 - 923
  • [8] CHEN CC, 1995, J IMMUNOL, V155, P3538
  • [9] THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS) - IMMUNOLOGY AND POTENTIAL IMMUNOTHERAPY
    DARVILLE, T
    GIROIR, B
    JACOBS, R
    [J]. INFECTION, 1993, 21 (05) : 279 - 290
  • [10] Systemic inflammatory response syndrome
    Davies, MG
    Hagen, PO
    [J]. BRITISH JOURNAL OF SURGERY, 1997, 84 (07) : 920 - 935